Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: TJG who wrote (1879)	7/11/1998 7:19:00 PM
From: ROSARIO	Respond to of 2395

Excellent Post!!! I agree, Bico jumped from about 35 cents to $7 per share the last time they made a huge press release like this. The cancellation of the reverse stock split is AWESOME!! Granted the company has had problems but they have turned the corner in my opinion. I will be adding another 250,000 shares on the open!!!

To: TJG who wrote (1879)	7/11/1998 7:20:00 PM
From: Terry D.	Read Replies (1) \| Respond to of 2395

TJG>>>>>Why is no clinical data out on the results of D1000 trials? I am heavy into bio med and have never seen a company so secretive about their trial results. If there is information it is public domain now, no proprietary rights. Why was the data not submitted to the FDA at the same time as CE mark was? I'm only into this for a few thousand, but think investors deserve an answer to this question. I have asked on the boards and called BICO numerous times requesting this information. Results=nada, zip, zero. Would you risk your life on a machine which had no trial data? Not this kid. steve....if you are willing to take a big gamble and a quick profit you might make a few bucks on the hype. I wouldn't hold long term tho. Regards Terry